Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure supports binding to specific enzyme active sites, enhancing selectivity and potency. Commonly employed in research settings to optimize drug candidates with improved metabolic stability and bioavailability. Also utilized in the preparation of prodrugs due to the presence of hydrolyzable ester and ether functionalities, allowing for controlled release of active metabolites.